BBNX (Beta Bionics) FCF Margin %: -91.25% (As of Mar. 2026)


BBNX Beta Bionics Inc BBNX
10 GF Score
Price $17.00
! 3 Warning Signs
View Full Analysis

What is Beta Bionics FCF Margin %?

Beta Bionics BBNX +1.71% 10 FCF Margin % is -91.25% as of Mar. 2026. GuruFocus rates BBNX with a GF Score™ of 10/100. The stock has 3 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Beta Bionics ranks worse than 80.05% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Beta Bionics's Free Cash Flow for the three months ended in Mar. 2026 was $-25.2 Mil. Beta Bionics's Revenue for the three months ended in Mar. 2026 was $27.6 Mil. Therefore, Beta Bionics's FCF Margin % for the quarter that ended in Mar. 2026 was -91.25%.

As of today, Beta Bionics's current FCF Yield % is -8.07%.

The historical rank and industry rank for Beta Bionics's FCF Margin % or its related term are showing as below:

BBNX' s FCF Margin % Range Over the Past 10 Years
Min: -34067.04   Med: -176.59   Max: -55.45
Current: -55.45

During the past 4 years, the highest FCF Margin % of Beta Bionics was -55.45%. The lowest was -34067.04%. And the median was -176.59%.

BBNX's FCF Margin % is ranked worse than
80.05% of 817 companies
in the Medical Devices & Instruments industry
Industry Median: -0.34 vs BBNX: -55.45

Beta Bionics FCF Margin % Related Terms

Beta Bionics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Beta Bionics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Bionics FCF Margin % Chart

Beta Bionics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
FCF Margin %
-34,067.04 -273.84 -79.34 -56.08

Beta Bionics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -115.13 -66.15 -36.73 -32.78 -91.25

BBNX vs CBLL, SIBN, TCMD: FCF Margin % Comparison

For the Medical Devices subindustry, Beta Bionics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beta Bionics FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beta Bionics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Beta Bionics's FCF Margin % falls into.


BBNX
10GF Score
Beta Bionics Inc BBNX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Bionics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Beta Bionics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-56.222/100.251
=-56.08 %

Beta Bionics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-25.209/27.626
=-91.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -91.25% mean?
Beta Bionics (BBNX) has a FCF Margin % of -91.25% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Beta Bionics and its competitors. According to the industry distribution chart, Beta Bionics ranks #654 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 80%.
Is Beta Bionics' FCF Margin % too high?
Beta Bionics' current FCF Margin % is -91.25%. Based on the distribution chart, Beta Bionics ranks #654 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beta Bionics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Beta Bionics' FCF Margin % compare to CBLL and SIBN?
According to the Medical Devices & Instruments industry distribution chart, Beta Bionics ranks #654 out of 817 companies for FCF Margin %. This places Beta Bionics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Beta Bionics and its competitors. Beta Bionics's current FCF Margin % is -91.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Bionics stock overvalued right now?
Beta Bionics (BBNX) has a current FCF Margin % of -91.25%. The current FCF Margin % is -91.25%. Beta Bionics' overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Beta Bionics (BBNX), the current FCF Margin % is -91.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beta Bionics Business Description

Address 11 Hughes, Irvine, CA, USA, 92618
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
10GF Score

Get the complete analysis for BBNX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.00
Price